Price Table
* Prices are based on daily market changes.
Date | Open | High | Low | Close | Volume | Delivery % | 20-Day sma | 50-Day sma | 200-Day sma |
---|
View More
Day High Low Range
Time | Lowest | Highest | Volume |
---|
Past Performance & Moving Averages
Day’s | Low high range | SMA | Stock performance | Nifty performance |
---|
PIVOT POINTS
NAME | S4 | S3 | S2 | S1 | PIVOT POINTS | R1 | R2 | R3 | R4 |
---|---|---|---|---|---|---|---|---|---|
CLASSIC | - | - | - | - | - | - | - | - | - |
WOODIE‘S | - | - | - | - | |||||
FIBONACCI | - | - | |||||||
CAMARILLA | - |
Trend Analysis
Key Data
Market cap | Book value | stock p/e | Dividend yield | roce | roe | sales growth (3Y) | face value (3Y) |
---|
Profile
ERIS
It was incorporated as “Eris Lifescience Private Limited” as on January 25, 2007, as a private limited company under the Companies Act 1956, at Ahmedabad, along with a certificate of incorporation granted by the Registrar of Companies, Gujarat, Dadra, and Nagar Haveli. According to a resolution of the Shareholders dated February 5, 2007, the company name was changed to “Eris Lifesciences Private Limited” and a fresh certificate of incorporation was being issued by the Registrar of Companies, Gujarat, Dadra, and Nagar Haveli as on February 9, 2007. Further, according to a conversion of the company to a public limited company, and as approved by the Shareholders via a resolution dated January 31, 2017, the company name was changed to “Eris Lifesciences Limited,” and the RoC also issued a fresh certificate of incorporation as on February 2, 2017.
Some of the Milestones:
- 2007:
- The incorporation of the company took place.
- It launched the “Eris” division focused on the cardiology and diabetes segment.
- 2008: It launched “Nikkos” division focused on gastroenterology and orthopedics segment.
- 2009: It launched the “Adura” division focused on the cardiology and diabetes segment.
- 2011: It launched the “Montana” division focused on the gynecology and pediatrics segment.
- 2012: It launched the “Inspira” division focused on the cardiology segment.
- 2014:
- It launched the “Victus” division focused on the anti-diabetes segment.
- It also set up the Assam Facility by the Company.
- 2015: It launched the “Eris 2” division focused on the pain management segment.
- 2016:
- It acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now, Aprica Pharmaceuticals Private Limited).
- It acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited.
- It acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited.
- 2017: It acquired the trademarks ‘UNION’, ‘REUNION’ and ‘BON UNION.’
Some of the Achievements:
- 2013:
- Frost & Sullivan awarded it the ‘Competitive Strategy Leadership’ award.
- It was awarded the ‘Emerging Companies Excellence’ award for scalability of the business model and managing operational efficiencies by Business Today and Yes Bank.
Trading and Investment Terminology